Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial)
NCT05100160
·
clinicaltrials.gov ↗
PHASE3
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
0 patient accrual
Conditions
Thoracic
Pulmonary Disease
Interventions
DRUG:
Gabapentin
OTHER:
Placebo
Sponsor
M.D. Anderson Cancer Center